300 related articles for article (PubMed ID: 10808208)
41. Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA).
Ito JI; Chandrasekar PH; Hooshmand-Rad R
Bone Marrow Transplant; 2005 Nov; 36(10):873-7. PubMed ID: 16113663
[TBL] [Abstract][Full Text] [Related]
42. Importance of open lung biopsy in the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies.
Kim K; Lee MH; Kim J; Lee KS; Kim SM; Jung MP; Han J; Sung KW; Kim WS; Jung CW; Yoon SS; Im YH; Kang WK; Park K; Park CH
Am J Hematol; 2002 Oct; 71(2):75-9. PubMed ID: 12353303
[TBL] [Abstract][Full Text] [Related]
43. Disseminated invasive aspergillosis in an apparently immunocompetent host.
Raja NS; Singh NN
J Microbiol Immunol Infect; 2006 Feb; 39(1):73-7. PubMed ID: 16440127
[TBL] [Abstract][Full Text] [Related]
44. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
[TBL] [Abstract][Full Text] [Related]
45. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
[TBL] [Abstract][Full Text] [Related]
46. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.
Kontoyiannis DP; Boktour M; Hanna H; Torres HA; Hachem R; Raad II
Cancer; 2005 Jun; 103(11):2334-7. PubMed ID: 15844093
[TBL] [Abstract][Full Text] [Related]
47. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation.
Kontoyiannis DP; Chamilos G; Lewis RE; Giralt S; Cortes J; Raad II; Manning JT; Han X
Cancer; 2007 Sep; 110(6):1303-6. PubMed ID: 17614303
[TBL] [Abstract][Full Text] [Related]
48. Twenty-nine cases of invasive aspergillosis in neutropenic patients.
Saghrouni F; Ben Youssef Y; Gheith S; Bouabid Z; Ben Abdeljelil J; Khammari I; Fathallah A; Khlif A; Ben Saïd M
Med Mal Infect; 2011 Dec; 41(12):657-62. PubMed ID: 22036518
[TBL] [Abstract][Full Text] [Related]
49. Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: results of a 5 year retrospective study.
Saugier-Veber P; Devergie A; Sulahian A; Ribaud P; Traore F; Bourdeau-Esperou H; Gluckman E; Derouin F
Bone Marrow Transplant; 1993 Aug; 12(2):121-4. PubMed ID: 8401356
[TBL] [Abstract][Full Text] [Related]
50. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.
Paterson PJ; Seaton S; Prentice HG; Kibbler CC
J Antimicrob Chemother; 2003 Nov; 52(5):873-6. PubMed ID: 14519673
[TBL] [Abstract][Full Text] [Related]
51. Utility of percutaneous lung biopsy for diagnosing filamentous fungal infections in hematologic malignancies.
Nosari A; Anghilieri M; Carrafiello G; Guffanti C; Marbello L; Montillo M; Muti G; Ribera S; Vanzulli A; Nichelatti M; Morra E
Haematologica; 2003 Dec; 88(12):1405-9. PubMed ID: 14687995
[TBL] [Abstract][Full Text] [Related]
52. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
[TBL] [Abstract][Full Text] [Related]
53. Low incidence of invasive aspergillosis in allogeneic stem cell transplant recipients receiving amphotericin B inhalation prophylaxis.
Nihtinen A; Anttila VJ; Ruutu T; Juvonen E; Volin L
Transpl Infect Dis; 2012 Feb; 14(1):24-32. PubMed ID: 21749589
[TBL] [Abstract][Full Text] [Related]
54. Inhaled amphotericin B for prophylaxis against invasive Aspergillus infections.
Mohammad RA; Klein KC
Ann Pharmacother; 2006 Dec; 40(12):2148-54. PubMed ID: 17148653
[TBL] [Abstract][Full Text] [Related]
55. Invasive aspergillosis in a paediatric haematology department: a 15-year review.
Crassard N; Hadden H; Piens MA; Pondarré C; Hadden R; Galambrun C; Pracros JP; Souillet G; Basset T; Berthier JC; Philippe N; Bertrand Y
Mycoses; 2008 Mar; 51(2):109-16. PubMed ID: 18254746
[TBL] [Abstract][Full Text] [Related]
56. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.
Labbé AC; Su SH; Laverdière M; Pépin J; Patiño C; Cohen S; Kiss T; Lachance S; Sauvageau G; Busque L; Roy DC; Roy J
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1192-200. PubMed ID: 17889356
[TBL] [Abstract][Full Text] [Related]
57. [Invasive aspergillosis].
Caillot D; Mannone L; Kara-Slimane F
Rev Prat; 2001 Apr; 51(7):731-7. PubMed ID: 11387668
[TBL] [Abstract][Full Text] [Related]
58. Aspergillus tracheobronchitis after allogeneic bone marrow transplantation.
Machida U; Kami M; Kanda Y; Takeuchi K; Akahane M; Yamaguchi I; Kakiuchi C; Takeda N; Tanaka Y; Chiba S; Honda H; Hirai H
Bone Marrow Transplant; 1999 Nov; 24(10):1145-9. PubMed ID: 10578166
[TBL] [Abstract][Full Text] [Related]
59. Pulmonary complications after bone marrow transplantation: an autopsy study from a large transplantation center.
Roychowdhury M; Pambuccian SE; Aslan DL; Jessurun J; Rose AG; Manivel JC; Gulbahce HE
Arch Pathol Lab Med; 2005 Mar; 129(3):366-71. PubMed ID: 15737032
[TBL] [Abstract][Full Text] [Related]
60. [Invasive aspergillosis in hematooncological patients: advantages and disadvantages of various diagnostic methods, treatment options and financial costs of therapy].
Rácil Z; Mayer J; Kocmanová I; Wagnerová B; Winterová J; Folber F; Lengerová M; Moulis M; Zácková D; Smardová L; Janíková A; Navrátil M; Dvoráková D; Vorlícek J
Vnitr Lek; 2008 Feb; 54(2):157-68. PubMed ID: 23687707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
